Bispecific anti-Cmet/anti-Her2 antibodies
US10143749B2 · kind B2 · utility
2Cited by
5References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 28, 2014 |
| Grant date | Dec 4, 2018 |
| Priority date | — |
| Expiry date | Jun 6, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There are provided an anti-c-Met/anti-Her2 bispecific antibody, and a method for preventing and/or treating cancer using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.